Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
J Clin Microbiol ; 51(9): 3076-8, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23784129

RESUMEN

Misidentifications of Burkholderia pseudomallei as Burkholderia cepacia by Vitek 2 have occurred. Multidimensional scaling ordination of biochemical profiles of 217 Malaysian and Australian B. pseudomallei isolates found clustering of misidentified B. pseudomallei isolates from Malaysian Borneo. Specificity of B. pseudomallei identification in Vitek 2 and potentially other automated identification systems is regionally dependent.


Asunto(s)
Automatización de Laboratorios/métodos , Técnicas de Tipificación Bacteriana/métodos , Burkholderia pseudomallei/aislamiento & purificación , Errores Diagnósticos , Australia , Burkholderia pseudomallei/clasificación , Burkholderia pseudomallei/metabolismo , Geografía , Humanos , Malasia , Sensibilidad y Especificidad
3.
Open Forum Infect Dis ; 8(10): ofab460, 2021 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-34646909

RESUMEN

BACKGROUND: Burkholderia pseudomallei, the causative agent of melioidosis, is intrinsically resistant to a broad range of antibiotics, including aminoglycosides. In Sarawak, Malaysia, a high proportion of melioidosis cases are caused by gentamicin-susceptible isolates. There are limited epidemiological and clinical data on these infections. METHODS: We conducted a retrospective study of culture-confirmed melioidosis among adults admitted to Bintulu Hospital in Sarawak, Malaysia, from January 2011 until December 2016. RESULTS: One hundred forty-eight adults with culture-confirmed melioidosis were identified. Of 129 (87%) tested, 84 (65%) had gentamicin-susceptible B pseudomallei. The average annual incidence of melioidosis was 12.3 per 100 000 population, with marked variation between districts ranging from 5.8 to 29.3 per 100 000 population. Rural districts had higher incidences of melioidosis and overwhelmingly larger proportions of gentamicin-susceptible B pseudomallei infection. Significantly more patients with gentamicin-susceptible infection had no identified risk factors, with diabetes less frequently present in this group. Ninety-eight percent had acute presentations. Pneumonia, reported in 71%, was the most common presentation. Splenic abscesses were found in 54% of those imaged. Bacteremia was present in 88%; septic shock occurred in 47%. Forty-five (35%) patients died. No differences in clinical, laboratory, or outcome characteristics were noted between gentamicin-susceptible and gentamicin-resistant infections. CONCLUSIONS: Gentamicin-susceptible B pseudomallei infections are common in Sarawak and dominate in the high-incidence rural interior regions. Clinical manifestations and outcomes are the same as for gentamicin-resistant B pseudomallei infections. Further studies are required to determine if all gentamicin-susceptible B pseudomallei infections in Sarawak are clonal and to ascertain their environmental drivers and niches.

4.
Eur Heart J Case Rep ; 2(2): yty055, 2018 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-31020134

RESUMEN

INTRODUCTION: As a causal organism in infective endocarditis, Burkholderia pseudomallei is rare. Burkholderia pseudomallei is intrinsically resistant to aminoglycosides but a gentamicin-susceptible strain was discovered in Sarawak, Malaysian Borneo in 2010. We report the first occurrence of infective endocarditis due to the gentamicin-susceptible strain of B. pseudomallei. CASE PRESENTATION: A 29-year-old man presented with pneumonia and melioidosis septicaemia. His condition was complicated with infective endocarditis and septic emboli to the brain. Despite difficulties in reaching a diagnosis, the patient was successfully treated using intravenous gentamicin and ceftazidime and was discharged well. DISCUSSION: The role of gentamicin in the treatment of the gentamicin-susceptible strain of B. pseudomallei remains unclear.

5.
Saudi J Kidney Dis Transpl ; 29(1): 207-209, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29456232

RESUMEN

Tranexamic acid (TXA) is an antifibrinolytic agent commonly used to achieve hemostasis. However, there have been a few case reports suggesting that high-dose intravenous TXA has epileptogenic property. In patients with renal impairment, even administering the usual recommended dose of TXA can induce seizure episodes. We present here a patient on hemodialysis who developed seizures after receiving two doses of TXA over 5 h period.


Asunto(s)
Antifibrinolíticos/efectos adversos , Cateterismo Venoso Central/efectos adversos , Hemorragia/tratamiento farmacológico , Diálisis Renal , Insuficiencia Renal Crónica/terapia , Convulsiones/inducido químicamente , Ácido Tranexámico/efectos adversos , Administración Intravenosa , Anciano , Anticonvulsivantes/uso terapéutico , Antifibrinolíticos/administración & dosificación , Hemorragia/etiología , Humanos , Masculino , Insuficiencia Renal Crónica/diagnóstico , Convulsiones/diagnóstico , Convulsiones/tratamiento farmacológico , Ácido Tranexámico/administración & dosificación , Resultado del Tratamiento
6.
Asian J Surg ; 30(1): 80-1, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17337378

RESUMEN

Djenkol beans or jering (Pithecellobium jeringa) is a traditional delicacy consumed by the local population in Malaysia. Jering poisoning or djenkolism is characterized by spasmodic pain, urinary obstruction and acute renal failure. The underlying pathology is an obstructive nephropathy, which is usually responsive to aggressive hydration and diuretic therapy. We present a case of djenkolism following ingestion of jering. The patient required urgent bilateral ureteric stenting following the failure of conservative therapy. Healthcare providers need to recognize djenkolism as a cause of acute renal failure and the public educated on this potential health hazard.


Asunto(s)
Lesión Renal Aguda/inducido químicamente , Anuria/inducido químicamente , Fabaceae/envenenamiento , Enfermedades Transmitidas por los Alimentos/etiología , Plantas Medicinales/envenenamiento , Humanos , Masculino , Persona de Mediana Edad
7.
PLoS Negl Trop Dis ; 11(6): e0005650, 2017 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-28599008

RESUMEN

BACKGROUND: Melioidosis is a serious, and potentially fatal community-acquired infection endemic to northern Australia and Southeast Asia, including Sarawak, Malaysia. The disease, caused by the usually intrinsically aminoglycoside-resistant Burkholderia pseudomallei, most commonly affects adults with predisposing risk factors. There are limited data on pediatric melioidosis in Sarawak. METHODS: A part prospective, part retrospective study of children aged <15 years with culture-confirmed melioidosis was conducted in the 3 major public hospitals in Central Sarawak between 2009 and 2014. We examined epidemiological, clinical and microbiological characteristics. FINDINGS: Forty-two patients were recruited during the 6-year study period. The overall annual incidence was estimated to be 4.1 per 100,000 children <15 years, with marked variation between districts. No children had pre-existing medical conditions. Twenty-three (55%) had disseminated disease, 10 (43%) of whom died. The commonest site of infection was the lungs, which occurred in 21 (50%) children. Other important sites of infection included lymph nodes, spleen, joints and lacrimal glands. Seven (17%) children had bacteremia with no overt focus of infection. Delays in diagnosis and in melioidosis-appropriate antibiotic treatment were observed in nearly 90% of children. Of the clinical isolates tested, 35/36 (97%) were susceptible to gentamicin. Of these, all 11 isolates that were genotyped were of a single multi-locus sequence type, ST881, and possessed the putative B. pseudomallei virulence determinants bimABp, fhaB3, and the YLF gene cluster. CONCLUSIONS: Central Sarawak has a very high incidence of pediatric melioidosis, caused predominantly by gentamicin-susceptible B. pseudomallei strains. Children frequently presented with disseminated disease and had an alarmingly high death rate, despite the absence of any apparent predisposing risk factor.


Asunto(s)
Melioidosis/epidemiología , Melioidosis/patología , Adolescente , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Malasia/epidemiología , Masculino , Estudios Prospectivos , Lluvia , Estudios Retrospectivos , Factores de Tiempo
8.
Eur J Rheumatol ; 3(3): 139-141, 2016 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-27733946

RESUMEN

Here we present a case report of three familial primary antiphospholipid syndrome (PAPS) patients from Malaysia. The three familial patients comprised two females and one male with a mean age of 26.3 years. The first diagnosis was made between 2005 and 2009, and all patients demonstrated deep vein thrombosis, high levels of IgM and IgG anticardiolipin antibodies, and received warfarin treatment international normalized ratio (INR) 2.0-3.0. The patients ceased to show clinical symptoms after treatment. Recently (August 2014), we investigated whether the levels of antiphospholipid antibodies remained elevated, and we found that seronegativity occurred in the patients. We suspect that prolonged anticoagulant treatment might be one of the causes of reduced levels of antiphospholipid antibodies in these familial PAPS patients.

9.
Clin Rheumatol ; 30(5): 615-21, 2011 May.
Artículo en Inglés | MEDLINE | ID: mdl-20886247

RESUMEN

The aim of our study is to describe the impact of tight control strategy on the care of RA patients in Sarawak General Hospital. We performed a prospective study of all patients with a diagnosis of RA who received treatment at the Rheumatology Clinic in Sarawak General Hospital over a 1-year period. Systematic DAS-driven treatment adjustments aimed to achieve low disease activity (DAS 28-ESR <2.6) were carried out in the clinic over the 1-year period. Disease activity and treatment regimes of all 142 patients were collected for at baseline and 1 year later for statistical analysis. Our patients have a significantly lower DAS 28 with a mean of 2.99 ± 0.95 compared with baseline of 4.31 ± 1.34 (p < 0.000). More patients were in remission 1 year later compared to baseline (36.6% vs 11.3%). Tight control strategy has a positive impact on the care of RA patients in our centre. By optimising the care of RA through tight control strategy, RA can be better controlled in our centre.


Asunto(s)
Artritis Reumatoide/terapia , Reumatología/métodos , Actividades Cotidianas , Adulto , Antiinflamatorios no Esteroideos/uso terapéutico , Antirreumáticos/uso terapéutico , Femenino , Humanos , Malasia , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Inducción de Remisión , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Factores de Tiempo , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA